Wealthspire Advisors (Maryland)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Wealthspire Advisors (Maryland)'s PFE Position: Q3 2020 in Review
Wealthspire Advisors (Maryland) increased its Pfizer (PFE) stake by 2% in Q3 2020, buying an estimated $102K and bringing the position to 151,361 shares worth $5.27M. The position accounts for 0.19% of the portfolio, ranked #67.
Wealthspire Advisors (Maryland) first reported a position in PFE in Q4 2015 and has held it in 20 quarters since. The position peaked at $7.91M in Q4 2018. 2,508 funds tracked by Wall St. Rank hold PFE as of Q3 2020.
- Wealthspire Advisors (Maryland) held 151,361 shares of Pfizer worth $5.27M as of Q3 2020.
- Wealthspire Advisors (Maryland) bought 2,919 Pfizer shares in Q3 2020, an estimated $102K.
- Pfizer made up 0.19% of Wealthspire Advisors (Maryland)'s portfolio in Q3 2020, its #67 holding.
- Wealthspire Advisors (Maryland) first reported a position in Pfizer in Q4 2015 and has held it in 20 quarters since.
- Wealthspire Advisors (Maryland)'s Pfizer position peaked at $7.91M in Q4 2018.
- 2,508 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.
Based on Wealthspire Advisors (Maryland)'s 13F filing for Q3 2020, filed 13 Nov 2020.